CTMX vs JNJ: Which Stock is Better?
Side-by-side comparison of CytomX Therapeutics Inc and Johnson & Johnson in 2026
CTMX
CytomX Therapeutics Inc
$5.37
JNJ
Johnson & Johnson
$218.21
Key Metrics Comparison
| Metric | CTMX | JNJ | Winner |
|---|---|---|---|
| Market Cap | $913.26M | $525.73B | JNJ |
| P/E Ratio | 17.97 | 21.10 | CTMX |
| EPS (TTM) | $0.30 | $10.34 | JNJ |
| Revenue Growth | -0.8% | 0.1% | JNJ |
| Gross Margin | 100.0% | 68.4% | CTMX |
Analyze CTMX
Full quant analysis
Analyze JNJ
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CTMX or JNJ a better investment?
Comparing CTMX and JNJ: CytomX Therapeutics Inc has a market cap of $913.26M while Johnson & Johnson has $525.73B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CTMX and JNJ?
CTMX (CytomX Therapeutics Inc) and JNJ (Johnson & Johnson) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CTMX or JNJ?
Based on P/E ratios, CTMX trades at a lower multiple (18.0x vs 21.1x).
Which is growing faster: CTMX or JNJ?
JNJ has higher revenue growth at 0.1% vs -0.8% for CTMX.
Which company is more profitable: CTMX or JNJ?
CytomX Therapeutics Inc (CTMX) has higher gross margins at 100.0% compared to 68.4% for JNJ.
Which is the larger company: CTMX or JNJ?
Johnson & Johnson (JNJ) is larger with a market cap of $525.73B compared to $913.26M for CTMX.
Should I buy CTMX or JNJ in 2026?
Both CTMX and JNJ have investment merit. CTMX trades at $5.37 while JNJ trades at $218.21. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CTMX and JNJ stock?
Key differences: Market Cap ($913.26M vs $525.73B), P/E Ratio (18.0x vs 21.1x), Revenue Growth (-0.8% vs 0.1%), Gross Margin (100.0% vs 68.4%).